Crude oil prices, particularly Brent crude, have been rising amid concerns over the U.S.-Iran conflict. However, the Relative Strength Index (RSI), a key momentum indicator, has not matched these price gains, signaling that the rally might be losing strength. This divergence suggests that buyers could be running out of steam, potentially leading to a price pullback or stabilization. Investors should watch for further signals to confirm whether the rally will continue or reverse.
Crude oil prices provide market context for readers. As of Oct 28, 2026 00:21 WIB, 87 of 150 priced US stocks on Pluang rose while 63 fell. Notable movers include JBLU at USD 2.81 with a 1-day change of +18.78%, SOFI at USD 16.61 up 14.83%, and BA at USD 170.78 down 9.31%.
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
Eli Lilly has outpaced Novo Nordisk in the GLP-1, obesity, and Type 2 Diabetes market, achieving a $1.21 trillion valuation. While Novo Nordisk's share price has fallen back after earlier gains and revenue growth remains flat, its management's strate...
argenx SE announced it will stop its Phase 3 UNITY study of efgartigimod subcutaneous for moderate-to-severe Sjögren's disease after an independent committee found the trial unlikely to meet its primary goal. This decision caused the company's stock ...
Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a sharp stock price drop triggered by a new U.S. federal strategy targeting the dialysis market. The Department of Health and Human Services announced a plan to incre...
Pomerantz LLP is investigating ClearPoint Neuro and its executives for possible securities fraud following a significant stock price drop. The decline occurred after ClearPoint's partner, uniQure, announced that their Huntington's disease treatment f...
